Journal article
Hydroxychloroquine against COVID-19: A critical appraisal of the existing evidence
Abstract
Hydroxychloroquine (HCQ) has sparked much interest in the therapeutics of the Coronavirus Disease 2019 (COVID-19) pandemic. Its antiviral properties have been studied for years; regarding the Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2), it has been shown that HCQ may act at multiple levels. These extend from the initial attachment of the virus to the respiratory epithelium to the inhibition of its replication by the …
Authors
Tselios K; Lupus Clinic TWH; Skendros P; First Department of Internal Medicine & Laboratory of Molecular Hematology DUOT
Journal
European Journal of Rheumatology, Vol. 7, No. Supp2, pp. s110–s116
Publisher
AVES Publishing
Publication Date
8 2020
DOI
10.5152/eurjrheum.2020.2064
ISSN
2147-9720